-transparent.png){kind=logo}
The antiestrogenic potency of benz[a]anthracene-3,9-diol, as well as its 7- and 12-methyl derivatives, was evaluated by measuring he inhibition in the onset of estrus brought about by this compound in ovariectomized rats treated with 17beta-estradiol. At a dose of 0.5 mg and 7,12-dimethyl derivative caused a decrease in the percentage of rats in estrus from 78 to 44%. This decrease is identical with that caused by 0.05 mg of nafoxidine.
Related Publications
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
June 1978,
Cancer research,
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
May 1995,
Steroids,
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
March 1984,
Carcinogenesis,
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
December 1983,
IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans,
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
January 1979,
Drug and chemical toxicology,
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
September 1968,
Journal of medicinal chemistry,
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
February 2017,
Physical chemistry chemical physics : PCCP,
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
October 1968,
Justus Liebigs Annalen der Chemie,
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
August 1977,
Proceedings of the National Academy of Sciences of the United States of America,
C E Morreal, and
D K Sinha, and
S L Schneider, and
R E Bronstein, and
J Dawidzik
November 1974,
Research communications in chemical pathology and pharmacology,
